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Inflammatory and cytotoxic effects of acrolein,
nicotine, acetylaldehyde and cigarette smoke
extract on human nasal epithelial cells
David M Comer1,2, Joseph Stuart Elborn1,2† and Madeleine Ennis1*†
Abstract
Background: Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear
which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly
responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals
contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have
immunomodulatory effects in primary nasal epithelial cell cultures (PNECs).
Methods: PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein,
nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments
were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by
ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V
staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method.
Results: CSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure
time. Acrolein was pro-inflammatory for the PNEC cultures (30 μM exposure for 4 h inducing a 2.0 fold increase in IL-8
release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory
properties (0.6 fold IL-8 release after 50 μM exposure to nicotine for 24 h), and acetylaldehyde was without effect.
Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB
activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death.
Conclusions: Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death
predominantly by apoptotic mechanisms.
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Background
Nasal and sinus inflammation is common in chronic
obstructive pulmonary disease (COPD) and contributes
to the decline in lung function [1]. The responses of the
bronchial epithelium to cigarette smoke (CS) have been
well characterised [2], but effects on the nasal epithelium,
also important in respiratory disease, are not as well
understood. Sinonasal symptoms in COPD range from
75% [3] to as much as 88% [4]. The most commonly
reported upper airway symptoms are rhinorrhea, nasal ob-
struction and sneezing [3,5]. Overall, these observations
confirm that significant sinonasal inflammation is present
and important in COPD and in smokers [6]. Therefore,
dissecting the effects of cigarette smoke on nasal epithelial
cells is important in terms of our understanding of inflam-
mation and COPD.
Although CSE is widely used in cell culture research it
is an imperfect tool, having been criticised as a poor
substitute for the prolonged, chronic exposure of to-
bacco smoke to which many smokers are exposed [7].
Recently investigators have opted to study individual
components of CS [8-10]. The inherent complexity of
CSE makes it difficult to identify any individual chemical
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mediating a particular cellular effect of interest. Further-
more, it is difficult to understand the relevance of any
particular CSE concentration and duration of exposure.
Even if inferences are made on the basis of findings from
CSE data, these experiments do not duplicate in an
entirely satisfactory manner all of the components that
exist in vivo.
CSE has been reported to decrease basal IL-8 in alveolar
cell lines [11]. However, other groups have demonstrated
that CSE can have stimulatory properties in alveolar cell
lines [11,12] and in primary human macrophages [13] and
to heighten the release of IL-8 in submerged healthy bron-
chial epithelial cell cultures after stimulation [14]. These
discrepant findings in alveolar cell lines are almost cer-
tainly a result of the different concentrations of CSE used,
with lower concentrations stimulating cells and higher
concentrations being anti-inflammatory. It is however
much more difficult to provide a valid explanation for
the inconsistent findings in the primary cell research.
Although there is no consensus in relation to the propen-
sity for tobacco smoke to induce a pro-inflammatory re-
sponse in bronchial epithelial cells, the weight of evidence,
on balance, would support a pro-inflammatory [2,15-17]
as opposed to an anti-inflammatory effect [18,19].
Despite the diverse chemicals contained within cigarette
smoke, its acute effects on cell function and toxicity
appear to be due largely to volatile thiol-reactive compo-
nents, of which acrolein is most abundant and reactive
[20]. A toxicological risk assessment of the chemical con-
stituents of cigarette smoke indicated that acrolein and
acetylaldehyde had the highest overall non-cancer risk
index for respiratory disease [21]. In vivo studies demon-
strate that acrolein may be responsible for many of the
respiratory responses to cigarette smoke exposure. For
example, an acute exposure to acrolein diminishes pul-
monary defence against bacterial and viral infection in ani-
mals [22,23], and a chronic exposure induces bronchial
lesions and mucous hyperplasia [24]. Nicotine, a small
molecule organic alkaloid, is another important constitu-
ent in cigarette smoke which not only is strongly related
to addiction [25], but also is at least partially responsible
for the airway irritation and inflammation induced by
whole CS [26,27]. Acetylaldehyde, in concert with nico-
tine, contributes to addiction [28]. Furthermore, acety-
laldehyde impairs mucociliary clearance in the lung,
leading to an impaired host defense [29]. Therefore,
acrolein, nicotine and acetylaldehyde are among the
most important and relevant chemicals in cigarette
smoke.
In addition to the activity of inflammatory cells in the
airway, heightened proteolytic activity and greater levels
of oxidative stress, an imbalance between apoptosis
and proliferation of structural cells in the lung prob-
ably contributes to the pathogenesis of COPD [30].
The mechanism of cell death due to CSE exposure
remains controversial [31,32]. In these experiments, we
hypothesized that acrolein, nicotine and acetylaldehyde,
known to be contained within CS, individually immuno-
modulate primary nasal epithelial cells (PNEC) cultures.
CSE has been shown to be cytotoxic to nasal epithelial cell
cultures [33], and we aimed to establish which, if any, of
these individual chemicals were contributory.
Methods
Study subjects and ethics statement
Nasal brushings were obtained from 19 healthy volun-
teers. All 19 subjects were non-smokers, nor did any
have chronic respiratory symptoms or require any ther-
apy used for respiratory diseases. Bilateral nasal brush-
ings were performed using a bronchial cytology brush
(TeleMed Systems Inc., MA, USA) from the medial
aspect of the inferior turbinate as previously described
[34]. The brush was then removed and rinsed thoroughly
in a 15 ml polypropylene tube containing sterile PBS. Pro-
vided the patient tolerated the procedure, two brushings
were obtained from each nostril. At the end of the proced-
ure, DMEM medium containing 10% Fetal Bovine Serum,
Penicillin Streptomycin antibiotics (Invitrogen, USA) and
Primocin (Invivogen, USA) was added. This study was
approved by the Office for Research Ethics Committees
Northern Ireland (REC: 09/NIR03/42) and all participants
provided written informed consent.
Cell culture and soluble mediator release
PNECs were expanded in bronchial epithelial growth
medium (BEGM, Promocell) with 100 units/ml Penicillin
Streptomycin antibiotics (Invitrogen, USA) and 100 μg/
ml Primocin (Invivogen, USA). Cells were confirmed to
be epithelial in origin by randomly staining cultures by
immunocytochemical staining for cytokeratin expression
(Figure 1). Cells (passage 2-3; 1 × 105 cells/ml) were
seeded in purified bovine collagen coated (PureCol;
Advanced Biomatrix) 12-well plates and cultured for
24 h. Cells were stimulated with LPS from Pseudomonas
aeruginosa (Sigma-Aldrich), either with or without pre-
treatment with acrolein, nicotine or acetylaldehyde as out-
lined in the results section. Separate cultures were treated
with 5% CSE alone. After appropriate stimulation, cell-free
supernatants were collected and stored at -80° for future
IL-8 and IL-6 measurement using the Duoset ELISA kits
(R&D Systems) according to the manufacturer’s instruc-
tions. Cells were used for protein expression studies.
Immunofluorescence
Cells were seeded on coverslips at a density of 1 × 105
cells/ml. The following day, cells were fixed in 4% PFA
and washed in PBS. After permeabilisation with 0.2%
Triton-X 100 (Sigma, Dorset, UK), cells were treated
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with a 1:100 dilution of rabbit anti-cytokeratin-5 pri-
mary antibody (Abcam, Cambridge, UK) overnight at
4°C. The primary antibody was detected using a 1:500
dilution of Alexafluor 568 goat anti-rabbit IgG (Invitro-
gen Ltd., Paisley, UK). Nuclei were stained with DAPI
(Vector Laboratories, Peterborough, UK). Images were
captured using LAS AF (Leica) acquisition software.
CSE preparation
CSE was prepared by a modification of the method of
Richter et al. [17] One commercial Marlboro Red cigarette
(0.8 mg nicotine; 10 mg Tar; 10 mg carbon monoxide) was
combusted with a modified syringe-driven apparatus. The
smoke was bubbled through 25 ml of media over 5 min by
drawing 35-ml volume of smoke every 15 s. The resulting
suspension was filtered through a 0.2 μm pore-size filter
to remove large particles and bacteria. This solution was
regarded as “100% CSE” and freshly generated for each
experiment, and subsequently serially diluted with culture
medium to obtain a final 5% working concentration. The
optical density was constant when comparing a series of
5% CSE solutions prepared in this manner [35].
Annexin-PI staining
Apoptosis was analysed using Annexin V (Av) and Pro-
pidium Iodide (PI) staining (eBioscience, UK). Events
which were negative for Av and PI were considered to
represent viable cells, those positive for Av, but negative
for PI represented early apoptosis and events positive for
both Av and PI secondary necrosis. To eliminate debris
from the analysis the discrimination level was set to 100.
Cells, adjusted to 1 × 105 cells per 100 μl, were sus-
pended in binding buffer and incubated with the
fluorochrome-conjugated Av for 15 min. Subsequently,
after washing, cells were re-suspended in fresh binding
buffer and stained with PI. In order to set gates and
establish appropriate compensation settings, cells were
stained with PI alone, Av alone, and both PI and Av. In
order to obtain positive control samples for early apop-
tosis and necrosis respectively, cells were treated with
5 μM staurosporin and 0.1% Triton-X respectively for 4 h.
TUNEL assay
After treating PNECs with individual chemicals as de-
scribed in the results section, cultures were analysed for
apoptosis using the Click-It TUNEL assay (Invitrogen, UK).
Cells, after being fixed and permeabilised, were exposed to
a reaction cocktail overnight at room temperature. Cells
were then treated with a reaction buffer additive mixture
for 30 min, and cells mounted onto glass coverslips with
mounting media and DAPI. Images were captured using
LAS AF (Leica) acquisition software.
Western blotting
For Western blotting, cells were lysed in radioimmunopre-
cipitation assay buffer (Sigma-Aldrich, UK). The protein
concentration was determined by BCA protein assay kit
(Fisher Scientific, UK). Equal amounts of protein (15 μg/
lane) were separated in a 10% SDS gel, and transferred to
a polyvinylidene difluoride sheet by electroelution with a
Figure 1 Immunocytochemistry for cytokeratin 5 in nasal epithelial cell cultures. Primary nasal epithelial cell cultures were stained with a
rabbit anti-human antibody against cytokeratin 5 (1:100). The primary antibody was detected using a secondary antibody coupled to Alexafluor
568 (1:500). Nuclei were stained blue with DAPI (×40). Each quadrant represents DAPI staining alone (upper left), staining for cytokeratin 5 alone
(upper right), and staining for both DAPI and cytokeratin 5 (lower left).
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constant voltage of 100 V for 90 min at room temperature.
After blocking with 0.1% Tween 20 supplemented with
PBS (T-PBS) containing skimmed milk, the sheet was in-
cubated with a 1:1,000 dilution phosho-NF-κB antibody
(Cell Signalling, UK) at 4°C overnight. The sheet was then
washed three times with T-PBS, and incubated with goat
HRP conjugated anti-rabbit antibody (1:3,000 dilution;
Abcam, UK) for 1 h at room temperature. After washing
with T-PBS three times, immunoreactive protein bands
were revealed with an enhanced chemiluminescence
western blot analysis system. After being “stripped”
using a Western Blot Stripping Buffer (Thermoscientific,
UK), membranes were re-probed with a polyclonal anti-
body against IκB-α and for beta-actin (both 1:1,000
dilution).
To determine the effects of individual chemicals on
caspase-3 activation in PNEC cultures, cultures were
treated as described in the results section. For the detec-
tion of cleaved caspase-3, a 1:1,000 dilution of primary
antibody was used (Cell Signalling, UK). The sheet was
then washed three times with T-PBS, and incubated with
goat HRP conjugated anti-rabbit antibody (1:3,000 dilu-
tion; Abcam, UK) for 1 h at room temperature and
developed as described.
TransAM NF-κB assay
Nuclear extracts were prepared using a nuclear extrac-
tion kit from Active Motif (Belgium, UK) according to
manufacturer’s instructions. The Active Motif Trans-
AM NF-κB ELISA kit (Belgium, UK) was used to deter-
mine the levels of p65 in nuclear extracts. In brief, 2 μg
of nuclear extract, diluted to 20 μL, was added to the
wells coated with oligonucleotides containing the NF-κB
consensus binding site. The primary antibodies used to
detect NF-κB recognise an epitope on p65 that is access-
ible only when NF-κB is activated and bound to its
target DNA. After the addition of secondary antibodies
conjugated with HRP and substrate, absorbance was
read at 450 nm (with a reference wavelength at 650 nm).
In order to monitor for specificity, competitive binding
assays were performed. Wild-type or mutated consensus
oligonucleotides were added to the wells containing
immobilised oligonucleotides before the addition of nu-
clear extracts.
Statistics
Statistical analysis was performed using SPSS version
17.0 (SPSS inc., Chicago, IL, USA). Data are presented
as median values ± interquartile range. Comparisons be-
tween groups were performed using the nonparametric
Kruskal-Wallis test for multiple comparisons and the
Mann–Whitney test for two groups. A p value of less
than 0.05 was considered significant.
Results
Soluble mediator release
Cells were confirmed to be epithelial by staining with
cytokeratin-5 (Figure 1). Constitutive and stimulated re-
lease of IL-8 and IL-6 was used to determine PNEC acti-
vation. Pre-treating PNEC cultures with 30 μM acrolein
for 1 h or 4 h increased the basal constitutive release of
IL-8, and heightened the release of IL-8 after subsequent
stimulation with Pseudomonas aeruginosa LPS (PA LPS;
Sigma-Aldrich, UK). This was statistically significant after
a 4 h incubation period with acrolein (Figure 2). Repeating
experiments using 50 μM nicotine (Sigma-Aldrich, UK)
demonstrated anti-inflammatory effects for the PNEC cul-
tures after a 4 h and 24 h incubation period, although only
reached statistical significance for the latter incubation
period. 50 μM acetylaldehyde (Sigma-Aldrich, UK) was
without effect on cytokine release after a 4 h and 24 h
incubation period. Treating PNEC cultures with CSE for
24 h heightened the release of IL-8 (Figure 2). In separate
experiments, PNEC cultures were treated for 4 h with
acrolein (10–50 μM) which demonstrated a dose respon-
sive increment in IL-8 release up to 30 μM with evidence
of cytotoxicity at higher concentrations determined using
the MTT assay. Results for IL-6 followed a similar trend
for all experiments (data not shown).
Effects of acrolein, nicotine, acetylaldehyde and CSE on
activation of caspase-3 in PNEC cultures
Using an antibody against the cleaved fragment of cas-
pase 3 (17–19 kDa), we demonstrated by Western blot-
ting that treatment with both acrolein and nicotine for
1 h increased levels of active caspase 3, which was most
pronounced for acrolein. Repeating experiments with
acetylaldehyde for 1 h did not activate caspase 3. A
brief exposure for 1 h to 5% CSE cleaved caspase 3, in a
concentration dependant manner (Figure 3).
Effects of acrolein, nicotine, acetylaldehyde and CSE on
cell viability in PNEC cultures
Annexin-V staining demonstrated that 50 μM nicotine
exposure for 24 h induced predominantly early apoptosis
in PNEC cultures. After treatment with 50 μM acrolein
for 4 h, there was evidence of predominantly necrosis.
Acetylaldehyde had minimal effects on cell viability, and
5% CSE for 24 h induced apoptosis and secondary ne-
crosis. Events which were positive for apoptosis and ne-
crosis are shown (Figure 4 and Table 1). Apoptosis was
confirmed using the TUNEL assay for each stimulus
(Figure 5).
Effects of acrolein, nicotine, acetylaldehyde and CSE on
NF-κB activation
There was a significant increase in phosho-NF-κB pro-
tein levels after stimulation with 30 μg/ml acrolein for
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1 h, whereas 50 μM nicotine for 1 h reduced phosho-NF-
κB protein concentration measured from whole cell ly-
sates. Repeating experiments using 50 μM acetylaldehyde
had no effect on levels of phosho-NF-κB. 50% CSE height-
ened phosho-NF-κB after 1 h exposure. Levels of IκB-α
had an inverse relationship to phosho-NF-κB for all chem-
ical stimulation (Figure 6). Repeating experiments and de-
termining levels of active NF-κB p65 protein from nuclear
extracts provided similar results (Figure 7).
Discussion
Acrolein is pro-inflammatory and nicotine anti-inflam-
matory in PNEC cultures. In contrast, acetylaldehyde
was without effect on cytokine release. Nicotine in-
duced predominantly early apoptosis in the cultures,
whereas acrolein induced both apoptosis and overt
necrosis. Interestingly, a study exposing PNECs to CSE for
1 h, 2 h, and 4 h reported a time and dose-dependent
cytotoxicity of CSE [33]. Nicotine and acrolein increased
levels of active caspase 3; acrolein to a greater extent. Ex-
periments were repeated with CSE, containing all of these
chemicals, for comparison purposes. We exposed PNEC
cultures to CSE for a 4 h and a 24 h period to facilitate
comparison of our data with other published work. The
concentrations of CSE used can range from 100% CSE for
15 minutes [18] to a 1% CSE for 24 hours (in those studies
which use a single cigarette to prepare the initial “100%”
stock CSE) [12]. CSE also cleaved full length caspase 3, in-
duced early and late apoptosis after a 24 h exposure, and
was pro-inflammatory after this exposure time. Acrolein
and CSE increased, whereas nicotine reduced, levels of
active NF-κB.
Figure 2 IL-8 release from PNECs after 24 h treatment with PA LPS in the presence or absence of 30 μM acrolein for 1 h or 4 h, 50 μM
nicotine or 50 μM acetylaldehyde for 4 h or 24 h, and 5% CSE for 4 h or 24 h. PNEC cultures were treated with increasing concentrations of
LPS for 24 h ± pretreatment with acrolein, nicotine or acetylaldehyde (n = 4). Separate cultures were treated with 5% CSE for 4 h or 24 h (n = 4).
Data are displayed as median ± IQR. * p < 0.05. The control IL-8 concentration was 1310 ± 223 pg/ml.
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Treating submerged or air liquid interface PNEC cul-
tures with acrolein has been reported to suppress basal
IL-8 release [36], and acrolein inhibited LPS-induced
cytokine release from human alveolar macrophages
when used at a 25 μM concentration [37]. Further-
more, acrolein has been shown to reduce inflammatory
responses in human bronchial epithelial cell lines by
suppressing NF-κB activation [38]. The report demon-
strating anti-inflammatory properties of acrolein in
PNEC cultures acquired samples from subjects with
chronic rhinosinusitis, and so this may not reflect the
activity of acrolein from the PNEC cultures. Further-
more, those reports indicating that acrolein had anti-
inflammatory properties on epithelial cells had both
treated cultures for 30 minutes [36,38], whereas an
18 h exposure of acrolein in small airway epithelial cell
cultures was pro-inflammatory when similar concen-
trations of acrolein were used [39]. Therefore, and as
we have demonstrated in these experiments, it is clear
that exposure time is an important determinant as to
the effects of acrolein in airway epithelial cell cultures,
as is the case for treatment with CSE.
Nicotine had no significant effect on LPS-induced IL-8
production in the CF cell line, CFTE29o [40], but sup-
pressed inflammatory responses in human bronchial epi-
thelial cell lines after stimulation with LPS [41]. Our data
indicate that in healthy PNEC cultures, nicotine was anti-
inflammatory. In contrast, Tsai et al. demonstrated that
treatment of bronchial epithelial cell lines with nicotine
induced IL-8 production, and this effect was mediated by
both ERK and JNK MAPK, but yet not through the p38
pathway [42]. In their study the cell lines were exposed to
nicotine for a shorter period of time (4 h, 8 h, 10 h) using
a lower concentration (5 μM). In our studies acetylalde-
hyde appears to have no role in terms of the immuno-
modulatory effects of CSE. The differences observed by
previous investigators are likely to be a result of the differ-
ent cell types used in their respective experiments.
The concentrations of nicotine and acrolein in the
alveolar lining fluid in smokers are of the order of
30 μM and 80 μM respectively [43]. However, maximum
stimulation of IL-8 was achieved in primary small airway
epithelial cells after stimulation with 30 μM acrolein for
18 h, decreasing thereafter with higher concentrations,
attributed to the cytotoxic effects of treatment [39].
Similar results have been reported using the human
bronchial cell line, HBE1, with no detectable apoptosis
using a flow cytometry method after exposure to 25 μM
acrolein for 12 h, but clearly present with higher concen-
trations [44]. We also report that the optimal acrolein
concentration is in the 30 μM range for cell culture
experiments, with a marked reduction in cell viability at
50 μM using the MTT assay, rendering the release of
IL-8 difficult to interpret at this particular concentration.
Figure 3 Effect of acrolein and nicotine on caspase-3 activation in PNEC cultures determined using western blotting. Western blots of
cleaved caspase 3 in healthy PNECs (with beta-actin loading controls). Blot A: lanes 1–3 represent treatment of PNECs with 0, 5, 50 μM nicotine
(1 h); blot B: lanes 1–3: 0, 10, 50 μM acrolein (1 h); blot C: lanes 1–3 represent treatment of PNECs with 0, 5, 50 μM acetylaldehyde (1 h) and blot
D lanes 1–3: 0%, 5%, 50% CSE (1 h) respectively.
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Nicotine has been reported to have anti-inflammatory
effects in inflammatory bowel disease, and reduces
inflammatory cytokine release in alveolar macrophages
[45-47]. Previous studies have reported that nicotine
exerts its anti-inflammatory function to activation of its
receptor, nAChR, and as a consequence, inhibition of
the NF-κB pathway [48,49]. Furthermore, nicotine has
the potential to inhibit TLR-2 mediated inflammation in
response to TLR-2 agonists in CF cell lines [40]. Unfor-
tunately, the use of nicotine as a therapeutic agent is
limited by its negative side effects including cardiovas-
cular disease, hypertension, cancer and gastrointestinal
disorders [50].
Figure 4 Effect of acrolein, nicotine, acetylaldehyde and CSE treatment on cell viability. In each plot, the horizontal axis represents
intensity of staining for Annexin V and vertical axis intensity of staining for PI (determined in the FL1 and FL3 plot respectively, both logarithmic
scale). Dot plots represent (A) untreated cells, (B) cells treated with Triton-X for 4 h, (C) cells treated with 5 μM staurosporin for 4 h, (D) cells
treated with media alone for 4 h, (E) cells treated with 50 μM nicotine for 24 h, (F) cells treated with 50 μM acrolein for 4 h, (G) cells treated with
50 μM acetylaldehyde for 24 h, and (H) cells treated with 5% CSE for 24 h.
Table 1 Annexin-V/Propidium iodide analysis of acrolein,










Media 24 h 99.1% 0.4% 0.4% 0.1%
Nicotine 24 h 39.7% 45.5% 13.0% 1.8%
Acrolein 4 h 26.3% 2.2% 39.8% 31.7%
Acetylaldehye 24 h 97.4% 0.2% 2.0% 0.4%
5% CSE 24 h 51.8% 19.1% 25.6% 3.5%
Percentages of events positive for apoptosis and necrosis are shown
corresponding to dot-plots D-H in Figure 4.
Comer et al. BMC Pulmonary Medicine 2014, 14:32 Page 7 of 11
http://www.biomedcentral.com/1471-2466/14/32
CSE has been reported to induce apoptosis in primary
bronchial epithelial cells [51,52], and primary nasal
epithelial cells [33], by some but not all investigators
[53,54]. Interestingly, one group reported that cigarette
smoke condensate (CSC) inhibited apoptosis, but yet
caused necrosis in human umbilical vein endothelial
cells [55]. Furthermore, recent research using primary
bronchial epithelial cells indicated that CSE caused ne-
crosis rather than apoptosis [56]. This group prepared
CSE using 10 ml of media, and so could be considered
to be more than twice as concentrated when compared
to our CSE preparation. In addition, the epithelial cells
were exposed to the CSE for 48 h, and so it is not particu-
larly surprising that no apoptosis was evident as the cells
had undergone necrosis. CSC, which also contains the
lipid soluble fractions of volatile smoke, induces apoptosis
in A549 cells [57]. It is difficult to relate this to other CSE
preparations for comparison purposes, or to the in vivo
airway of the smoker, but it provides evidence that apop-
tosis can be induced in cell culture with various aqueous
CSE preparations. Interestingly, CSE induces cell death in
bronchial smooth muscle cells which is blocked by the
addition of N-acetylcysteine [45].
The three methods we opted to use in order to de-
termine the loss of cell viability, when considered in
isolation, are not ideal. Although the TUNEL nick-end
labeling method is increasingly applied to investigate
active cell death, many investigators do not regard the
technique to be acceptable [55,58]. It has been suggested
that DNA fragmentation, which is the fundamental as-
pect which the TUNEL assay measures, is common to
different types of cell death, and so on this basis it can-
not itself be relied upon to specifically measure apop-
tosis [58]. Cell death can occur by mechanisms which
are independent of caspase activity [59], and annexin-V
staining can give false positives due to damage to the cell
membrane induced during the detachment of the cells
by trypsin/EDTA. However, despite the shortcomings of
the individual assays, and taking all of the evidence to-
gether, our data indicate that acrolein, nicotine and CSE
are inherently cytotoxic, and that CSE causes cell death
by apoptotic mechanisms.
Figure 5 Effect of acrolein, nicotine, acetylaldehyde and CSE on apoptosis in PNEC cultures using TUNEL assay. Nasal epithelial cells
were grown on coverslips and treated with (A) PBS or (B) DNase I solution for the negative and positive control respectively. Separate samples
were treated with (C) 50 μM acrolein for 4 h, (D) 50 μM nicotine for 24 h, (E) 50 μM acetylaldehyde for 24 h or (F) 5% CSE for 24 h. Levels of
apoptosis were determined using the Click-iT reaction according to manufacturer’s instructions.
Comer et al. BMC Pulmonary Medicine 2014, 14:32 Page 8 of 11
http://www.biomedcentral.com/1471-2466/14/32
In contrast to our findings, other groups have demon-
strated that CSE increased phosphorylated NF-κB, in-
duced DNA damage, yet was protective against apoptosis
in BEAS-2B cells [54]. This may be attributable to the fact
that cell lines were used and not primary cells, and also
likely because a relatively brief 30 minute exposure of CSE
was used, a much shorter duration to that which we
adopted. Interestingly, acrolein induced apoptosis in the
bronchial epithelial cells line, HBE1, which was attributed
to the intracellular generation of oxidants [44].
Conclusion
Our data demonstrate that acrolein and nicotine, when
used at concentrations which are of relevance in the air-
way of cigarette smokers, stimulate and immunosup-
press PNEC cultures respectively. Acetylaldehyde, on the
other hand, had no effect. Both acrolein and nicotine
should be considered toxic substances to cell cultures,
and particularly so for acrolein. As acrolein heightened
IL-8 release, yet still caused loss of cell viability, this
finding at least suggests that the reduced IL-8 release
after nicotine treatment cannot merely be attributed to
loss of cell viability. This is supported by the reduced
levels of phosho-NF-κB apparent after nicotine treat-
ment. Finally, exposure to CSE heightened phosho-NF-
κB levels in the PNEC cultures. Overall our data confirm
the understanding that CSE is cytotoxic, and that some
of the chemicals contained within it can individually
immunomodulate and induce cell death in PNEC cul-
tures to varying degrees.
Figure 7 Effect of acrolein, nicotine and acetylaldehyde on
NF-κB p65 activation in PNEC cultures determined using the
TransAM NF-κB p65 kit. Nuclear extracts from PNEC cultures after
treatment with 0, 10, 30 μM acrolein (1 h), 0, 5, 50 μM nicotine (1 h),
0, 10, 50 μM acetylaldehyde (1 h) or media, 5% CSE or 50% CSE (1 h)
were assayed for NF-κB p65 activation using the TransAM NF-κB p65
Kit (n = 5). Data are displayed as median ± IQR. *p < 0.05.
Figure 6 Effect of acrolein, nicotine and acetylaldehyde on NF-κB expression in PNEC cultures determined using western blotting.
Western blot of phosho-NF-κB and IκB-α protein expression in PNECs (with beta-actin loading controls). Blot A: lanes 1–3 represent treatment of
PNECs with 0, 10, 30 μM acrolein (1 h); blot B: lanes 1–3: 0, 5, 50 μM nicotine (1 h); blot C: lanes 1–3 represent treatment of PNECs with 0, 10,
50 μM acetylaldehyde (1 h) and blot D lanes 1–3: media, 5% CSE, 50% CSE (1 h). Densitometry included for phosho-NF-κB: actin ratio (n = 5 for
each group). Data are displayed as median ± IQR. *p < 0.05.
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